https://www.marketscreener.com/quote/stock/ZYDUS-LIFESCIENCES-LIMITE-34067618/news/Cadila-Healthcare-India-s-Cadila-to-end-late-stage-trials-of-potential-COVID-19-vaccine-in-March-30941348/?utm_source=telegram&utm_medium=social&utm_campaign=share